Sosei Group ^Companies

Sosei Group is a Japanese biopharmaceutical company that focuses on developing and commercializing innovative drugs. With a strong emphasis on research and development, the company aims to address various medical conditions such as Alzheimer's disease, schizophrenia, cancer, migraine, addiction, and metabolic disease. Sosei Group utilizes advanced technologies, including GPCR structure-based drug design, peptide platform technologies, and nanotechnology, to create a robust product pipeline with first-in-class potential. The company has already achieved significant success by bringing three medicines to the market, including two COPD bronchodilators and an emergency contraceptive, which generate stable revenue streams for further growth.